Clayton-based Prolog Ventures is teaming with a Swiss company on a new fund that will invest in health and wellness startups.
The Swiss company, Lonza, is a manufacturer of pharmaceutical and specialty ingredients with annual sales of $4.8 billion. The fund, to be managed by Prolog, will invest in North American food, supplement, personal care or home-care startups that “maintain, protect or preserve the health and well-being of people and companion animals.”
Lonza said it expects the fund to invest in two or three businesses a year.
Prolog was founded in 2000 to invest in medical and plant-science startups. It currently manages two wellness-focused funds whose investments include Spindrift, a brand of fruit-flavored sparkling water, and Zeel, an on-demand massage company.